FM
ISEE

Frazier Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Frazier Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,838,402
Closed -$30.7M – 37
2021
Q4 		$30.7M Hold
1,838,402
– – 2.37% 17
2021
Q3 		$29.9M Sell
1,838,402
-706,098
-28% -$7.68M 2.39% 12
2021
Q2 		$16.1M Hold
2,544,500
– – 1.48% 15
2021
Q1 		$15.7M Buy
2,544,500
+50,000
+2% +$304K 1.26% 17
2020
Q4 		$17.2M Buy
2,494,500
+130,000
+5% +$832K 1.33% 16
2020
Q3 		$13.3M Hold
2,364,500
– – 1.2% 15
2020
Q2 		$12.1M Buy
+2,364,500
New +$9.85M 1.06% 17

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Frazier Management's ISEE Position: Q1 2022 in Review

Frazier Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2022, closing a stake of 1,838,402 shares — an estimated $30.7M sold.

Frazier Management first reported a position in ISEE in Q2 2020 and held it in 7 quarters. The position peaked at $30.7M in Q4 2021. 163 funds tracked by Wall St. Rank hold ISEE as of Q1 2022.

  • Frazier Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 1,838,402 IVERIC bio, Inc. Common Stock shares in Q1 2022, an estimated $30.7M.
  • Frazier Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Frazier Management's IVERIC bio, Inc. Common Stock position peaked at $30.7M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.